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Bioﬁlm structures are the most resistant form of active microorganisms against
sanitation, disinfection, and sterilization processes. One of the speciﬁc properties of
bioﬁlm is the development of antibiotic resistance that can be up to 1,000-fold greater
than planktonic cells. Enterococcus faecium is a human pathogen that causes
nosocomial bacteremia and at the present time, it is well known that most of the
chronic infections are bioﬁlm-based. Recent evidence suggested that subinhibitory
concentrations (sub-MICs) of antibiotics have an important role in the evolution of
antibiotic resistance and induction on bioﬁlm formation. Based on this information, we
aimed to determine the effect of subinhibitory antibiotic concentrations on bioﬁlm
formation and the role of the antibiotic concentrations on the enterococcal surface
protein gene (esp). To determine the impact of clinically important antibiotics on
bioﬁlm production, crystal violet assay was used. Then, the effect of sub-MICs of
antibiotics on the expression of the esp gene was investigated by quantitative real-time
PCR. Bioﬁlm production assays show that MIC/2 of erythromycin (ERT; 512 μg/ml),
MIC/32 of vancomycin (VAN; 16 μg/ml), MIC/64 of streptomycin (STR; 32 μg/ml),
and MIC/128 of kanamycin (KAN; 4 μg/ml) values induce maximum bioﬁlm
production compared with the control. According to q-PCR results, sub-MIC values
of ERT, VAN, and STR antibiotics were found to enhance esp gene expression. In
addition, despite the increasing bioﬁlm production after KAN treatment, the antibiotic
was not effective on the esp expression.
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Introduction
Antibiotics target essential bacterial structures, such as cell wall and cellular
pathways including DNA, RNA, and protein synthesis mechanism. They have
been used to treat several infectious diseases. The long-term use of antibiotics in
recent years has resulted in appearance of multidrug-resistant (MDR) bacterial
pathogens, such as Enterococci [1, 2].
Enterococci, known as opportunistic pathogens, are naturally found in
intestinal microﬂora and oral cavity of humans and animals. Two most common
Enterococcus species (Enterococcus faecalis and Enterococcus faecium) are
capable of producing bioﬁlms, which are bacterial communities attached to a
biotic or an abiotic substrate encased in a matrix. E. faecium is an important global
cause of bioﬁlm-related infections. Bioﬁlms are dependent on multiple genetic
factors, such as esp, gelE, and fsr locus [3, 4]. Cell wall-associated protein
implicated in bioﬁlm formation is an enterococcal surface protein (Esp) coded by
esp gene. It was ﬁrst identiﬁed in E. faecalis as a large surface-anchored protein
from infection-derived isolates [5]. An esp homologue has been identiﬁed in
E. faecium and this gene is localized on pathogenicity islands in both species
[6–8]. Studies suggested that there was a strong correlation between esp and the
forming of bioﬁlms. Toledo-Arana et al. [9] reported that 93.5% of esp-positive
isolates could form bioﬁlms on polystyrene, whereas none of the esp-negative
isolates could produce bioﬁlms. The investigators suggested that the N-terminal
domain of Esp is sufﬁcient for bioﬁlm production, mutation on the N-terminal
domain region of Esp in E. faecalis strain causes less bioﬁlm production [10]. The
esp-positive strains were also identiﬁed as strong bioﬁlm producers compared with
esp-negative isolates [11, 12]. In addition to that, researchers presented that
presence of a higher glucose concentration in the growth medium-regulated
bioﬁlm production [12–14]. In spite of that, other studies suggested that there
was no association between the presence of esp and bioﬁlm-forming ability and
the esp gene was not necessary for the production of bioﬁlm in E. faecalis and
E. faecium [15–18]. While some studies showed that esp is a certain factor for
bioﬁlm formation, others presented that bioﬁlm production needs other necessary
factors with esp.
Recent studies suggested that sub-MICs of antibiotics acted as signaling
molecules mediating variety of cell processes, such as gene transcription and
expression, quorum sensing, inter- or intra-species communication, and bioﬁlm
formation [19–23]. In addition, low concentrations of antibiotics may stimulate
different stress responses that might enable horizontal transfer of antibiotic resis-
tance genes among bacterial communities, which are found on bioﬁlm [23–26].
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Studies showed that some using antibiotic concentrations below the MIC
can signiﬁcantly induce bioﬁlm formation in a variety of Gram-positive and Gram-
negative bacterial species. Subinhibitory concentration of an aminoglycoside
antibiotic tobramycin induced bioﬁlm formation in Pseudomonas aeruginosa
and Escherichia coli [27]. Similarly, gentamicin (GEN) (>64 mg/ml, 2 ×MIC)
and tetracycline (>128 mg/ml, 4 ×MIC) were determined as the most effective
antibiotics against Salmonella Infantis bioﬁlm formation; however, bioﬁlm struc-
ture was induced with sub-MICs of nalidixic acid, spectinomycin, tetracycline,
and neomycin antibiotics treatment [28]. Balaji et al. [29] proved that 1/16 MIC
value of ﬂuoroquinolones increased bioﬁlm formation, whereas 1/2 MIC value of
them occurred inhibition effect on clinical isolates of Streptococcus pyogenes
bioﬁlm. The proof presented that inhibition and bioﬁlm formation were dose-
dependent [29]. Previous studies showed that sub-MIC amoxicillin antibiotic
levels induce methicillin-resistant Staphylococcus aureus bioﬁlm and this bioﬁlm
was thicker, contained more pillar and channel structures compared with the
control [30]. Kaﬁl et al. [31] investigated the effects of ampicillin (AMP),
vancomycin (VAN), GEN, and ceftizoxime antibiotics on bioﬁlm formation and
gene expression of colonization factors, such as E. faecalis antigen A gene (efaA),
aggregation substance gene (asa1), endocarditis and bioﬁlm-associated pilli gene
(ebpA), esp, and collagen adhesin gene (ace), in E. faecalis. They found that AMP,
VAN, and ceftizoxime did not have any signiﬁcant effect on bioﬁlm formation
while GEN induced bioﬁlm formation. And also for 12 strains, GEN, VAN, and
AMP increased expression of esp in the ratio of 50.9%, 89.1%, 131%, respec-
tively, by contrast, ceftizoxime reduced expression of esp (35%) [31]. One of the
most important goals in clinical microbiology is to prevent bioﬁlm-associated
infections. However, strategies for the treatment of bioﬁlm-related infections
should not be according to antibiotic concentrations that are effective only against
to planktonic cells. Currently, very little is known about the mechanism of
antibiotic induced bioﬁlm formation in genus Enterococcus. This study aims that
quantifying the use of low concentrations of antibiotics induces enterococcal
bioﬁlm formation and bioﬁlm-related gene expression.
Material and Methods
Bacterial isolates and culture conditions
Two bioﬁlm producer E. faecium strains, isolated from rectal sample, were
selected for this research. E. faecalis OG1RF was used as bioﬁlm producer control
ANTIBIOTIC-INDUCED BIOFILM PRODUCTION OF ENTEROCOCCUS FAECIUM 29
Acta Microbiologica et Immunologica Hungarica 65, 2018
strain. All strains were obtained from Prokaryote Genetic Laboratory Culture
Collection of Ankara University (Ankara, Turkey). Glycerol stock cultures were
activated in Tryptic Soy Broth (TSB,Merck, Germany) for overnight (18 h) at 37 °C.
Determination of minimum inhibitory concentration (MIC)
The MIC values of antibiotics were determined by the Clinical and
Laboratory Standards Institute broth microdilution method using Mueller–Hinton
Broth (Oxoid, UK). The strains were treated with clinically important antibiotics,
which are commonly used for the treatment of Enterococcus infections (Table I).
E. faecalis ATCC 29212 was used as the control strain and each experiment was
performed in duplicate.
Effect of subinhibitory concentrations (sub-MICs) of antibiotics on enterococcal
bioﬁlm formation
To determine induction of antibiotics on bioﬁlm production level of
E. faecium isolate, chloramphenicol (CHL), kanamycin (KAN), erythromycin (ERT),
AMP, VAN, streptomycin (STR), and GEN antibiotics were selected. A method
described by Extremina et al. [32] and Baldassarri et al. [33] was used to test the
microorganisms for bioﬁlm formation with minor modiﬁcations. The serial twofold
dilution of the antibiotics (from MIC/2 to MIC/128), 107 CFU/ml (OD595= 0.07)
overnight in E. faecium culture, and TSB supplemented with 1% glucose were added
to 96 well plates and incubated at 37 °C for 48 h. Negative control was only test broth,
and positive control was only bacteria. After 48 h growth at 37 °C, the plates were
gently washed thrice with phosphate buffered saline. The plates were allowed to dry
















E. faecium 84 R, 512 R, 4096 R, 512 R, 4096 R, 256 S R, 2048
E. faecium 95 R, 512 R, 4096 R, 1024 R, 512 R, 512 R, 2048 R, 2048
E. faecalis
OG1RF
S R, 2048 I, 4 R, 256 R, 64 R, 128 R, 512
E. faecalis
ATCC29212
S S S R, 32 S S S
Note: AMP: ampicillin; GEN: gentamicin; KAN: kanamycin; STR: streptomycin; CHL: chloramphenicol;
ERT: erythromycin; VAN: vancomycin; R: resistance; I: intermediate-level resistance; S: susceptible;
MIC: minimum inhibitory concentration.
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for 1 h at 60 °C and then ﬁxed using methanol (95%). For bioﬁlm quantiﬁcation,
200 μl of 1% crystal violet (CV) solution was added to each well and the plates were
allowed to stand for 30 min. The wells were subsequently washed thrice with steriled
H2O to wash off the excess CV. CV bounded to the bioﬁlm was extracted with 200 μl
of ethanol–acetone (80/20% v/v) and the absorbance of the extracted CV was
measured at 595 nm on ELISA Reader (ThermoScientiﬁc, Multiskan Go, USA).
Determination of esp gene expression by quantitative real-time PCR assay
Statistically signiﬁcant sub-MIC antibiotic values leading to bioﬁlm formation
in E. faecium 95 were selected for esp gene expression experiments. Antibiotic-
induced total RNA of clinical E. faecium 95 strain was extracted using Promega RNA
Isolation kit (Promega, USA). RNA concentrations were measured by NanoDrop
2000 (ThermoScientiﬁc, USA). cDNA synthesis was carried out using Transcriptor
First Strand cDNA Synthesis Kit (Roche, Switzerland). Quantitative real-time PCR
was done by esp primers; esp-F 5′TGGTGATGGAAACCCTGACGA-3′, and esp-R
5′-TTGCGCTTTGTGACCTGTTCC-3′ [34]. The q-PCR assay was performed in
Roche Light Cycler® 480 II (Roche, Switzerland). The q-PCR ampliﬁcations were
performed in 10 μl reactions containing 1× Hot FirePol® EvaGreen® qPCR master
mix (Solis BioDyne, Esthonia), which includes Hot FirePol® DNA Polymerase,
EvaGreen® qPCR Buffer, 2.5 mM MgCl2, ultrapure dNTPs, EvaGreen
® dye and
RNase-free H2O, 0.5 pmol each primer, and 1 μl of the respective template cDNA
dilution. The q-PCR assay was optimized to the initial activation step of 95 °C for
15 min, followed by 40 cycles of denaturation at 95 °C for 15 s, annealing at 62 °C for
20 s for all the studied genes, extension at 72 °C for 20 s. All experiments were
performed in triplicate. The threshold cycle (Ct) of each well and data acquisition were
carried out using a software program from Real-Time Analysis Software Programme
(Light Cycler® 480 SW 1.5.0 SP4). The delta Ct (ΔCt) method was used for PCR
single gene data analysis. The normalized (ΔCt) for esp gene was calculated by
subtracting the mean Ct of the 16S rDNA housekeeping gene from the Ct of esp.
Statistical analysis
All bioﬁlm assays were performed in triplicate. In CV quantitative analysis,
the results were calculated by subtracting the median OD595 of the triplicates of the
control (test broth and E. faecium isolate, without antibiotic) from the median
OD595 of the triplicates of the sample. Statistical analysis was carried out by SPSS
(version 18, USA). One-way ANOVA test was preferred for microtiter plate assay
data. A p value less than 0.05 was considered statistically signiﬁcant.
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Results and Discussion
In this study, two E. faecium strains isolated from clinical samples were
subjected. Isolates were investigated for resistance against seven antibiotics that
are important to clinical treatment of Enterococcus infections (Table I). Both
strains were resistant to AMP, KAN, STR, CHL, ERT, and VAN at high levels. In
addition, E. faecium 95 strain showed resistance to GEN (MIC; 2,048 μg/ml),
whereas E. faecium 84 strain was sensitive. According to this result, both strains
were detected to exhibit multidrug resistance to clinically important antibiotics.
Bioﬁlm producing E. faecalisOG1RF as a control strain was found sensitive
to VAN only, whereas non-bioﬁlm producer E. faecalis ATCC29212 was
sensitive to all treated antibiotics except KAN (Table I). Considering this assay
results, it can be indicated that the strains capable of producing bioﬁlms are more
resistant to antibiotics. MDR strains may have acquired antibiotic-resistant genes
between bacteria that are present inside the bioﬁlm structure causing to be in-
hospital adapted clones. In addition, the uncontrolled use of the most common
antibiotics may have inﬂuenced the rise in prevalence of enterococcal infections in
humans. Recent reports showed that E. faecium strains isolated from clinical
samples had high degree of resistance to antibiotics [35–38]. In comparing the
bioﬁlm-forming strains (BIO+) with the non-bioﬁlm-forming strains (BIO−),
BIO+ strains were high frequency resistant than BIO− strains in clinical
E. faecium isolates [39]. This observation was also declared in some other studies
conducted by Sindhanai et al. [40] and Bhardwaj et al. [41].These results support
that the bioﬁlm forming promotes the virulence proﬁle to microorganisms [41].
The adherence ability of bioﬁlm was determined by estimation of obtained
OD values of E. faecium clinical isolates according to growth conditions including
planktonic culture and different sub-MIC antibiotic dilutions-broth media supple-
mented with 1% glucose. After 48 h exposure to sub-MIC antibiotics, the bioﬁlm
exhibited for these antibiotics on the plates the highest adherence ratio, which was
statistically signiﬁcant difference (p< 0.05). The activities of antimicrobial agents
were tested at sub-MICs against E. faecium 95, 84, and E. faecalis OG1RF
bioﬁlms are shown in Figures 1–3, respectively. According to bioﬁlm induction
with sub-MIC of antibiotics results; CHL, AMP, and GEN antibiotic values did
not induce bioﬁlm formation of E. faecium 95 strain. On the other hand, sub-MIC
antibiotic values of inducing maximum bioﬁlm formation in E. faecium 95
were MIC/128 of KAN (4 μg/ml), MIC/2 of ERT (512 μg/ml), MIC/32 of VAN
(16 μg/ml), and MIC/64 of STR (32 μg/ml) compared with control. The results
proved that the different concentrations of each antibiotic promoted the maximum
bioﬁlm production. In addition, concentration of antibiotic decreased except ERT,
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and the bioﬁlm formation was also induced. Only the ERT was the cause of the
increased bioﬁlm formation on E. faecium 84 strain whose value was found to be
MIC/4 (256 μg/ml) whereas tested sub-MIC antibiotic values had any signiﬁcant
difference on bioﬁlm formation of E. faecalis OG1RF. This study presented that
Figure 1. Bioﬁlm production levels of E. faecium 95 strain following incubation with sub-MIC
antibiotic levels. PC: positive control; CHL: chloramphenicol; KAN: kanamycin; ERT:
erythromycin; AMP: ampicillin; VAN: vancomycin; STR: streptomycin; GEN: gentamicin
Figure 2. Bioﬁlm production levels of E. faecium 84 strain following incubation with sub-MIC
antibiotic levels. PC: positive control; CHL: chloramphenicol; KAN: kanamycin; ERT:
erythromycin; AMP: ampicillin; VAN: vancomycin; STR: streptomycin
ANTIBIOTIC-INDUCED BIOFILM PRODUCTION OF ENTEROCOCCUS FAECIUM 33
Acta Microbiologica et Immunologica Hungarica 65, 2018
strains formed different amounts of bioﬁlm productivity. E. faecium 84 and
E. faecalis OG1RF were more powerful bioﬁlm producers compared with
E. faecium 95. Strains producing high levels of bioﬁlm in the absence of
antibiotics may not form bioﬁlm induction in the presence of sub-MIC antibiotic
values [42], for instance, sub-MIC levels of azithromycin showed inhibition effect
on P. aeruginosa bioﬁlm formation [43]. The demonstration of differences in the
formation of antibiotic-induced bioﬁlms according to strains shows that a single
model system cannot be established for treatment. In this case, it is necessary to
conduct strain-based control.
Quantitive real-time PCR assay was used to evaluate the effect of sub-MIC
of KAN, ERT, VAN, and STR on esp gene as one of the responsible genes on
colonization of enterococci in selected strain E. faecium 95. Transcriptions of esp
gene were strongly increased by MIC/2 of ERT (512 μg/ml), MIC/32 of
VAN (16 μg/ml), and MIC/64 of STR (32 μg/ml). Although the MIC/128 of
KAN (4 μg/ml) induced bioﬁlm formation, this concentration has no effect on the
esp expression (Figure 4). As the similar results, Kaﬁl et al. [31] showed,
although expression of esp gene increased with GEN and VAN, it was reduced
with ceftizoxime and AMP antibiotics. There are several virulence factors
relating to bioﬁlm, such as ace, esp, efaA, ebpA, and asa1 in Enterococci
[32, 44]. As based to this study, KAN-induced bioﬁlm formation may not
only depend on the induction of esp but also other virulence genes. Other
components, such as extracellular DNA, may also be effective on the bioﬁlm.
Figure 3. Bioﬁlm production levels of E. faecalis OG1RF strain following incubation with sub-MIC
antibiotic levels. PC: positive control; CHL: chloramphenicol; KAN: kanamycin; ERT:
erythromycin; AMP: ampicillin; STR: streptomycin; GEN: gentamicin
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We showed that virulence gene expression patterns can be changed by
exposure to antibiotics below MIC and there is no single mechanism of
antibiotic-induced bioﬁlm formation. There are limited studies about the role
of antibiotics on enterococcal bioﬁlm formation. More studies are needed to
determine whether there is a relationship between bioﬁlm inducibility and
response to therapy. Genes responsible for bioﬁlm formation should be
investigated by knockout studies.
Conclusions
Antibiotic dosages in clinical treatment are generally chosen according to
MICs of antibiotics against planktonic cells. Although MIC has been used as a
gold standard to determine antimicrobial sensitivities of bacteria, the MIC
value is not predictive of a particular antibiotic choosing in clinical efﬁcacy
because of the bioﬁlm forming ability in bacteria. In addition, cells buried in
deep within a bioﬁlm matrix may be exposed to sub-MIC concentrations of
antibiotics because of diffusion gradients. The data from our experiments
showed that certain concentrations of chosen antibiotics stimulate bioﬁlm
production of clinically isolated E. faecium strain. Commonly using antibiotics
as VAN in treatment of clinical enterococcal infections provokes the bioﬁlm
formation at low concentrations. We concluded that antibiotic concentrations
for struggle with pathogens need to be designated carefully. In addition,
induction of esp expression via sub-MICs of antibiotics may cause difﬁculties
at accomplished by antibiotic therapy for eradicating persistent enterococcal
infections associated with bioﬁlms. Future studies as generation of mutant
libraries will probably elucidate the mechanisms of bioﬁlm induction by sub-
MIC antibiotic levels.
Figure 4. esp gene expression rate after antibiotic exposure in E. faecium 95
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